{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:39Z","timestamp":1779433839536,"version":"3.53.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Dopamine remains a widely used inotrope in acute heart failure and cardiorenal syndrome; however, its administration carries a substantial risk in vulnerable patients. Current evidence suggests that conventional dosing strategies may lead to adverse cardiovascular outcomes. Here, we report a case highlighting the importance of conservative dopamine titration and structured monitoring to optimize both efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A high-risk patient with acute decompensated heart failure presented with progressive dyspnea, oliguria, and hypotension. The patient exhibited significant hemodynamic instability, raising concerns about the use of dopamine as an inotropic agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The clinical evaluation supported a diagnosis of acute decompensated heart failure with concurrent cardiorenal syndrome based on reduced urine output, elevated creatinine levels, pulmonary congestion, and echocardiographic findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Dopamine infusion was initiated at a conservative starting dose (\u22641.5 \u03bcg\/kg\/min), During subsequent cautious upward titration, the patient developed symptomatic tachyarrhythmia, prompting immediate discontinuation of the infusion. Patient management was guided by a structured monitoring pathway, incorporating bedside clinical assessment, pharmacist input, and electronic clinical decision support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The initial dopamine infusion improved urine output and stabilized systemic blood pressure. However, during dose titration, the patient developed a symptomatic tachyarrhythmia with ventricular rates reaching 180 bpm, classified as a \u201cprobable\u201d adverse drug reaction. Upon discontinuation of dopamine and with careful hemodynamic management, the arrhythmia resolved. The heart rate subsequently decreased from a pretreatment baseline of 106 beats\/min to a safer range, underscoring the necessity of vigilant monitoring even with conservative initial dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case emphasizes that dopamine therapy should not follow a \u201cone-size-fits-all\u201d model. Conservative dosing, multidisciplinary monitoring, and the use of decision support tools can reduce medication errors and improve safety. Personalized inotrope strategies are essential in patients with high-risk heart failure patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046553","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:03:20Z","timestamp":1766203400000},"page":"e46553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Severe tachycardia induced by dopamine in an elderly patient with renal insufficiency: A case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7280-6468","authenticated-orcid":false,"given":"Hui","family":"Xu","sequence":"first","affiliation":[{"name":"Gaozhao Street Community Health Service Center, Jiaxing, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-142-7-200504050-00010","article-title":"Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.","volume":"142","author":"Friedrich","year":"2005","journal-title":"Ann Intern Med"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock.","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2024.04.055","article-title":"Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF.","volume":"84","author":"Biegus","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/FJC.0000000000001517","article-title":"A systematic review and meta-analysis of renin-angiotensin system inhibitors and angiotensin receptor neprilysin inhibitors in preventing recurrence after atrial fibrillation ablation.","volume":"83","author":"Sun","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure long-term registry.","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40266-024-01165-2","article-title":"Pharmacologic management of heart failure with preserved ejection fraction (HFpEF) in older adults.","volume":"42","author":"Hashemi","year":"2025","journal-title":"Drugs Aging"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11306-025-02291-7","article-title":"Metabolomic profiling of renal cyst fluid in advanced ADPKD: insights from dialysis and transplantation cohorts.","volume":"21","author":"Heckscher","year":"2025","journal-title":"Metabolomics"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/pgs-2021-0087","article-title":"Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients.","volume":"22","author":"Jiang","year":"2021","journal-title":"Pharmacogenomics"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"e13915","DOI":"10.1111\/1440-1681.13915","article-title":"\u03b2-Adrenergic receptor signalling pathway mediated antiarrhythmic activity of s-limonene in the rat heart.","volume":"51","author":"Santos","year":"2024","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.124.324762","article-title":"AMPK attenuation of \u03b2-adrenergic receptor-induced cardiac injury via phosphorylation of \u03b2-arrestin-1-ser330.","volume":"135","author":"Zhao","year":"2024","journal-title":"Circ Res"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jelectrocard.2023.10.007","article-title":"Left bundle branch pacing in alternating bundle branch block.","volume":"81","author":"Benezet-Mazuecos","year":"2023","journal-title":"J Electrocardiol"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"32517","DOI":"10.3402\/pba.v6.32517","article-title":"Cardiovascular KATP channels and advanced aging.","volume":"6","author":"Yang","year":"2016","journal-title":"Pathobiol Aging Age Relat Dis"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"20220710","DOI":"10.1515\/biol-2022-0710","article-title":"Research progress of AMP-activated protein kinase and cardiac aging.","volume":"18","author":"Qiu","year":"2023","journal-title":"Open Life Sci"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s11658-023-00510-4","article-title":"Disrupted cardiac fibroblast BCAA catabolism contributes to diabetic cardiomyopathy via a periostin\/NAP1L2\/SIRT3 axis.","volume":"28","author":"Lu","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MNH.0000000000000659","article-title":"TaleNeprilysin and neprilysin inhibition in chronic kidney disease.","volume":"30","author":"Judge","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00059-018-4683-5","article-title":"Cognitive performance of patients with chronic heart failure on sacubitril\/valsartan: a retrospective cohort study. [Kognitive leistungsf\u00e4higkeit unter sacubitril\/valsartan bei patienten mit chronischer herzinsuffizienz: eine retrospektive kohortenstudie].","volume":"44","author":"De Vecchis","year":"2019","journal-title":"Herz"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ehf2.13085","article-title":"Renin profiling predicts neurohormonal response to sacubitril\/valsartan.","volume":"8","author":"Vergaro","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/0886022X.2021.1879856","article-title":"Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats.","volume":"43","author":"Polina","year":"2021","journal-title":"Ren Fail"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amj.2024.11.009","article-title":"Evaluation of reduced-dose induction agents during endotracheal intubation in critical care transport.","volume":"44","author":"Fjeld","year":"2025","journal-title":"Air Med J"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13054-018-2124-8","article-title":"Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.","volume":"22","author":"Nguyen","year":"2018","journal-title":"Crit Care"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12872-022-02572-2","article-title":"Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study.","volume":"22","author":"Li","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-024-05016-9","article-title":"Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II.","volume":"28","author":"Zampieri","year":"2024","journal-title":"Crit Care"},{"key":"R28-20260522","first-page":"27","article-title":"Clinical decision support systems-based interventions to improve medication outcomes: a systematic literature review on features and effects.","volume":"35","author":"Shahmoradi","year":"2021","journal-title":"Med J Islam Repub Iran"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:12Z","timestamp":1779433392000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":28,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046553","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}